Abstract
Fifteen patients with Parkinson's disease and levodopa-induced motor fluctuations, were studied with repeated injections of apomorphine using two protocols to explore possible changes in the duration of motor response. One involved different interdose intervals; in the other, doses were given when the motor effects induced by the previous dose had just worn off. No significant change in the duration of motor response to sequential subcutaneous apomorphine with either protocol was found. The results suggest that rapid changes in receptor sensitivity during repeated intermittent dopaminergic stimulation do not contribute to the pathogenesis of Parkinsonian motor fluctuations.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Castro R., Abreu P., Calzadilla C. H., Rodriguez M. Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval. Psychopharmacology (Berl) 1985;85(3):333–339. doi: 10.1007/BF00428198. [DOI] [PubMed] [Google Scholar]
- Gancher S. T., Nutt J. G. Diurnal responsiveness to apomorphine. Neurology. 1987 Jul;37(7):1250–1253. doi: 10.1212/wnl.37.7.1250. [DOI] [PubMed] [Google Scholar]
- Gancher S. T., Woodward W. R., Boucher B., Nutt J. G. Peripheral pharmacokinetics of apomorphine in humans. Ann Neurol. 1989 Aug;26(2):232–238. doi: 10.1002/ana.410260209. [DOI] [PubMed] [Google Scholar]
- Grandas F., Obeso J. A. Motor response following repeated apomorphine administration is reduced in Parkinson's disease. Clin Neuropharmacol. 1989 Feb;12(1):14–22. doi: 10.1097/00002826-198902000-00002. [DOI] [PubMed] [Google Scholar]
- Kempster P. A., Frankel J. P., Bovingdon M., Webster R., Lees A. J., Stern G. M. Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1989 Jun;52(6):718–723. doi: 10.1136/jnnp.52.6.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marsden C. D., Parkes J. D. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet. 1976 Feb 7;1(7954):292–296. doi: 10.1016/s0140-6736(76)91416-1. [DOI] [PubMed] [Google Scholar]
- Shaw K. M., Lees A. J., Stern G. M. The impact of treatment with levodopa on Parkinson's disease. Q J Med. 1980;49(195):283–293. [PubMed] [Google Scholar]
- Vaamonde J., Luquin M. R., Obeso J. A. Levodopa consumption reduces dopaminergic receptor responsiveness in Parkinson's disease. Clin Neuropharmacol. 1989 Aug;12(4):271–284. doi: 10.1097/00002826-198908000-00004. [DOI] [PubMed] [Google Scholar]